Interesting article here: NEW YORK (Fortune) — Biotechs working on cell treatments seem poised to profit from President Obama’s decision to lift the ban on federal funding for embryonic stem cell research and the $15 billion in stimulus money marked for scientific research. But for investors, the best way to play the sector might be […]
The market for stem cell research products is poised for explosive growth with the lifting of restrictions on federal funding. Whether you are an established player in the stem cell market or considering entry into this fast growing market, Capitalizing on New Opportunities for Stem Cell Products is an indispensable resource for: Corporate strategy Business […]
BioInformatics, LLC has been working with our good friend John Boyce in helping promote the First Annual Consumer Genetics Show in Boston this coming June. I first met John when he was working with Helicos and retained us to do a number of custom market research studies to help refine their market strategy. John’s new […]
Pay Invoice
Latest Blogs
-
Assessing the Value of Product Attributes: Deciphering Consumer Preferences
April 25, 2024 10:28 am
-
How Market Research Supercharges Life Sciences Go-To-Market Strategies
April 24, 2024 12:34 pm
-
4 Key Components to a Winning Go-To-Market Strategy
April 24, 2024 12:28 pm
Sitemap
Your Data and Privacy
About Us
BioInformatics, part of the Science and Medicine Group, is the leading research and advisory firm serving the life science and diagnostic industries. Our expertise includes primary quantitative and qualitative research in addition to secondary research and published reports. We own a proprietary, international community of more than 55,000 scientists and biomedical researchers to provide insights that grow businesses and move markets. Our multi-disciplinary team is comprised of industry veterans, market research experts, and survey statisticians.